
Vensor 75mg Tablet SR
Marketer
Ryon Pharma
Salt Composition
Venlafaxine (75mg)
Overview Vensor 75mg Tablet SR
Deprexis 75mg Extended-Release Tablets treat depression and anxiety. By modifying brain chemistry, it alleviates anxiety symptoms like restlessness, poor concentration, tiredness, excessive perspiration, rapid heartbeat, racing thoughts, and irritability. Take Deprexis 75mg ER with food, at the same time daily for consistent blood levels. If a dose is missed, take it immediately upon remembering; don't skip doses and complete the prescribed course, even if feeling improved. Abrupt cessation may intensify symptoms. Common side effects include nausea, vomiting, sleep disturbances, reduced appetite, heightened anxiety, constipation, increased sweating, and sexual difficulties. Dizziness and drowsiness may occur; avoid driving or mentally demanding tasks until the medication's effects are known. These side effects are generally transient. Report persistent or bothersome side effects to your physician. Before starting Deprexis 75mg ER, disclose any kidney, heart, or liver conditions, or history of seizures. Report any unusual mood or behavioral shifts, worsening depression, or suicidal ideation to your doctor immediately.
Primary Ingredients of Vensor 75mg Tablet SR
No information provided. Unable to rephrase.
Uses of Vensor 75mg Tablet SR
Mood disorders encompassing depressive and anxiety symptoms
Major Benefits of Vensor 75mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 75mg Vensor SR tablet whole; avoid chewing, crushing, or fracturing it. Take it with a meal.
Common Side effects of Vensor 75mg Tablet SR:
- Nausea
- Vomiting
- Dizziness
- Insomnia (difficulty in sleeping)
- Decreased appetite
- Anxiety
- Constipation
- Increased sweating
- Sexual dysfunction
How to use Vensor 75mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Vensor 75mg Sustained-Release tablets should be taken with a meal.
How Vensor 75mg Tablet SR works:
Vensor 75mg Extended-Release tablets elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vensor 75mg Tablet SR and alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Prolonged-release Vensor 75mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Vensor 75mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant. Infants should be observed for lethargy and monitored for appropriate weight increase.
DrivingUNSAFE
Driving may be impaired by Vensor 75mg SR tablets, due to potential side effects. These side effects include dizziness, confusion, and visual disturbances like blurred vision, all of which can negatively impact driving ability.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Vensor 75mg sustained-release tablets. Dosage modification of Vensor 75mg sustained-release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Vensor 75mg extended-release tablets cautiously. Dosage modification of Vensor 75mg extended-release tablets may be necessary; physician consultation is advised.
What if you forget to take Vensor 75mg Tablet SR :
Should you forget to take a Vensor 75mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vensor 75mg Tablet SR
| Label | Value |
|---|---|
| Chemical Category | Anisole-based compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | SNRIs (serotonin-norepinephrine reuptake inhibitors) |
